Clinical trial

Phase I Cetuximab and Concurrent Radio-chemotherapy

NCT00522886

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-04-01

PhasePHASE1

Study timeline

Study start (unknown)2007-04-01Date precision: month

Registry last updated2011-07-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-small Cell Lung Cancerunresolved

Interventions

CetuximabDRUG · verified · RxNorm: cetuximab

Sponsors & collaborators

Maastricht Radiation Oncologylead sponsor

Academisch Ziekenhuis Maastrichtcollaborator

Merck Sharp & Dohme LLCcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00522886 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.